loading

なぜCara Therapeutics Inc(CARA)の株価が下がっていますか?

2024-09-24 の取引セッション中に、Cara Therapeutics Inc (CARA) 株の 7.08% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。
2023-12-18:

Shares of Cara Therapeutics Inc (CARA) dropped by 48.85% from $1.23 to $0.6291 in the trading on Monday, December 18, 2023. The reason why CARA down today is due to the outcome from Part A of the KIND 1 study, where oral difelikefalin, as an adjunct therapy to topical corticosteroids (TCS) for moderate-to-severe pruritus in adults with atopic dermatitis (AD), did not show a meaningful clinical benefit compared to TCS alone. As a result, Cara Therapeutics has decided to discontinue its clinical program in pruritus associated with atopic dermatitis.

$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
大文字化:     |  ボリューム (24 時間):